Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Holding MD?
Track your performance easily
MD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.62 - $16.41
Previous Close$14.96
Volume650.61K
Average Volume (3M)681.93K
Market Cap
$1.28B
Enterprise Value$1.75B
Total Cash (Recent Filing)$220.45M
Total Debt (Recent Filing)$683.65M
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Feb 13, 2025EPS Estimate
$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding85,880,487
10 Day Avg. Volume656,479
30 Day Avg. Volume681,929
Standard Deviation0.15
R-Squared0.28
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.70
Price to Sales (P/S)0.63
Price to Cash Flow (P/CF)3.40
P/FCF Ratio3.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.87
Enterprise Value/Gross Profit4.15
Enterprise Value/Ebitda5.59
Forecast
1Y Price Target
$15.92Price Target Upside7.42% Upside
Rating ConsensusHold
Number of Analyst Covering6
Pediatrix Medical Group News
PremiumCompany Announcements
Pediatrix Medical Group’s Financial Highlights and Future PlansBulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reported Q3:24 adjusted EBITDA of $60.2mm, up 19.4% year over year, beating consensus estimates by 7.2%.
Portfolio RestructuringPortfolio restructuring drives down unit costs, with controllable costs per same unit volume declining 2.7% y/y, reflecting the impact of the practice disposition activity.
Revenue And GrowthSame-unit revenue growth increased 5.2% y/y in Q3 driven by solid patient volumes.
Bears Say
Market TrendsOur July Birth Tracker suggests weak trends with births declining nearly 1% y/y.
Revenue ImpactThe company is expecting a $200 million negative revenue impact from planned divestitures of certain practices and facilities.
Sustainability Of DevelopmentsIt remains unclear how sustainable the positive developments around payer mix are.
---
Ownership Overview
1.43% Insiders
25.62% Mutual Funds
23.84% Other Institutional Investors
19.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MD FAQ
What was Pediatrix Medical Group’s price range in the past 12 months?
Pediatrix Medical Group lowest stock price was $6.62 and its highest was $16.41 in the past 12 months.
What is Pediatrix Medical Group’s market cap?
Currently, no data Available
When is Pediatrix Medical Group’s upcoming earnings report date?
Pediatrix Medical Group’s upcoming earnings report date is Feb 13, 2025 which is in 71 days.
How were Pediatrix Medical Group’s earnings last quarter?
Pediatrix Medical Group released its earnings results on Nov 01, 2024. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.368 by $0.072.
Is Pediatrix Medical Group overvalued?
According to Wall Street analysts Pediatrix Medical Group’s price is currently Undervalued.
Does Pediatrix Medical Group pay dividends?
Pediatrix Medical Group does not currently pay dividends.
What is Pediatrix Medical Group’s EPS estimate?
Pediatrix Medical Group’s EPS estimate is $0.37.
How many shares outstanding does Pediatrix Medical Group have?
Pediatrix Medical Group has 85,880,486 shares outstanding.
What happened to Pediatrix Medical Group’s price movement after its last earnings report?
Pediatrix Medical Group reported an EPS of $0.44 in its last earnings report, beating expectations of $0.368. Following the earnings report the stock price went up 23.458%.
Which hedge fund is a major shareholder of Pediatrix Medical Group?
Among the largest hedge funds holding Pediatrix Medical Group’s share is Caspian Capital LP. It holds Pediatrix Medical Group’s shares valued at 13M.
---
Pediatrix Medical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.92 (7.42% Upside)
$15.92 (7.42% Upside)
Hedge Fund Trend
Increased
By 557.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $553.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.15%
12-Months-Change
Fundamentals
Return on Equity
-29.85%
Trailing 12-Months
Asset Growth
-10.72%
Trailing 12-Months
Company Description
Pediatrix Medical Group
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
---
MD Earnings Call
Q3 2024
0:00 / 0:00
---
MD Stock 12 Month Forecast
Average Price Target
$15.92
▲(7.42% Upside)
Technical Analysis
Best Analysts Covering MD
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
-1.73%
reiterated a sell rating 7 months ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -1.73% per trade.
---